Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/31/2003WO2004000227A2 Use of thio-oxindole derivatives in treatment of skin disorders
12/31/2003WO2004000226A2 Liposomes containing biologically active compounds
12/31/2003WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003WO2004000224A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003WO2004000223A2 Rapidly disintegrating formulations for treating or preventing mucositis
12/31/2003WO2004000219A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
12/31/2003WO2004000215A2 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
12/31/2003WO2004000214A2 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions
12/31/2003WO2004000211A2 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000197A2 Quick dissolve compositions and tablets based thereon
12/31/2003WO2004000116A1 Devices and methodologies useful in body aesthetics
12/31/2003WO2004000045A2 Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof
12/31/2003WO2004000043A2 Nutraceutic compositions and food supplements containing nadh
12/31/2003WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
12/31/2003WO2004000034A2 Anthelmintic oral homogeneous veterinary pastes
12/31/2003WO2004000025A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
12/31/2003WO2004000016A2 Antimicrobial compositions, products and methods employing same
12/31/2003WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
12/31/2003WO2003089577A3 Antihelminthic anthraquinones and method of use thereof
12/31/2003WO2003089576A3 Anticancer anthraquinones and method of use thereof
12/31/2003WO2003088959A3 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
12/31/2003WO2003088953A3 Multiphasic diet
12/31/2003WO2003087308A3 Use of interleukin-24 to treat ovarian cancer
12/31/2003WO2003082893A8 Theraputic methods and uses of sapogenins and their derivatives
12/31/2003WO2003080021A3 Formulation comprising buprenorphine
12/31/2003WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/31/2003WO2003075901A3 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
12/31/2003WO2003075839A3 Methods of inducing terminal differentiation
12/31/2003WO2003074513A3 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/31/2003WO2003073999A3 Pini-modulating compounds and methods of use thereof
12/31/2003WO2003073985A3 New methods of using antiangiogenic agents
12/31/2003WO2003073979A3 Derivatives of azaspiro compounds for the treatment of pain
12/31/2003WO2003073918A3 Prevention of recurrence and metastasis of cancer
12/31/2003WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/31/2003WO2003072576A3 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
12/31/2003WO2003072055A3 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
12/31/2003WO2003069303A3 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
12/31/2003WO2003068939A3 Cks1 INHIBITORS
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
12/31/2003WO2003064638A3 Elongase gene and method for producing polyunsaturated fatty acids
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003WO2003061621A3 Dermal application system for aminolevulinic acid-derivatives
12/31/2003WO2003061605A3 Methods of treatment of chronic immune disease
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003060475A3 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
12/31/2003WO2003059288A3 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003057203A3 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours
12/31/2003WO2003057172A3 Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003051334A3 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
12/31/2003WO2003051295A3 Neutralization of stratum corneum to treat hyperkeratotic skin lesions
12/31/2003WO2003049746A3 Combination of cytochome p450 dependent protease inhibitors
12/31/2003WO2003042404A3 Breast cancer eradication program
12/31/2003WO2003037265A3 Method of treating viral infections
12/31/2003WO2003035058A3 Polymaleide compounds and their medical use
12/31/2003WO2003035004A9 Immunotherapy for reversing immune suppression
12/31/2003WO2003031597A3 Methods of inhibiting osteoclast activity
12/31/2003WO2003025174A3 Regulation of human mrp1-like protein
12/31/2003WO2003024383A3 Methods and apparatus for improved administration of analgesics
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003013499A3 Drugs for vasculopaties
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002078747A9 Pregabalin lactose conjugates
12/31/2003WO2002071070A3 β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002070068A3 Lipoxin analogs as novel inhibitors of angiogenesis
12/31/2003WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/31/2003WO2002055075A3 Compounds and methods for regulating cell differentiation
12/31/2003WO2002048110A3 Composition for regulating animal growth, method of manufacture and use thereof
12/31/2003WO2002047615A3 Oral compositions and use thereof
12/31/2003WO2002040055A3 Solutions and films of glycated chitosan
12/31/2003WO2002038143A3 Enhanced efficacy and safety of genotoxic therapy by p38 mapk modulation
12/31/2003WO2001006984A3 Small molecules useful in the treatment of inflammatory disease
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464880A New macrolides with antibacterial activity
12/31/2003CN1464878A Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
12/31/2003CN1464788A Pharmaceutical compositions for headache, migraine, nausea and emesis
12/31/2003CN1464787A Novel hormone composition
12/31/2003CN1463977A Process for extracting amygdalin and use thereof
12/31/2003CN1463975A Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof
12/31/2003CN1463972A Novel N-substituted pyridine Benzisoxazolone compound, method for making same and its pharmaceutical composition and use thereof
12/31/2003CN1463968A 2-aryl-trisubstituted indole acetamide derivative and medicinal use thereof
12/31/2003CN1463967A Opioid receptor containing 3-pyrroline, process for preparing the same and use thereof
12/31/2003CN1463762A Novel pessary and method for preparing same
12/31/2003CN1463748A A novel highly effective immunologic adjuvant originated from plants, method for making the same and use thereof
12/31/2003CN1463742A Pudendum nursing liquid containing extract of oceanic organism
12/31/2003CN1463741A Oral disinfecting and cleaning liquid containing extract of oceanic organism
12/31/2003CN1463738A A medicine for treating scald and burn, and method for preparing same
12/31/2003CN1463725A A pharmaceutical compound for treating diabetes and insuline resistance syndrome
12/31/2003CN1463720A Ginseng-leech capsule for treating coronary disease and stenocardia and process for preparing same
12/31/2003CN1463705A Panaxoside, lecithine refreshing and brain tonic and process for producing the same
12/31/2003CN1463704A Novel usage of Aspirin-DL-Lysine
12/31/2003CN1463703A Nasal cavity preparation for treating long-term allergic reaction coryza
12/31/2003CN1463702A Analgetic pharmaceutical composition
1 ... 5228 5229 5230 5231 5232 5233 5234 5235 5236 5237 5238 5239 5240 5241 5242 5243 5244 5245 5246 5247 5248 ... 7860